Browse studies
Find your next paid study
2 recruiting studies matching your filters
A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.
The purpose of this research is to test whether a blood-based 3D genome conformation mapping test called the Episwitch CiRT® can help to identify likelihood of…
CancerImmunotherapyPD-1+2 more
Oxford Biodynamics Inc.NCT06635954
Observational
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
To learn if monitoring blood levels of heart injury (troponin levels) in cancer participants treated with immune checkpoint inhibitors will lead to decreased h…
Immune Checkpoint Therapy
M.D. Anderson Cancer CenterNCT06337097